Abstract

The RIG-I-like receptors (RLRs) play a major role in sensing RNA virus infection to initiate and modulate antiviral immunity. They interact with particular viral RNAs, most of them being still unknown. To decipher the viral RNA signature on RLRs during viral infection, we tagged RLRs (RIG-I, MDA5, LGP2) and applied tagged protein affinity purification followed by next-generation sequencing (NGS) of associated RNA molecules. Two viruses with negative- and positive-sense RNA genome were used: measles (MV) and chikungunya (CHIKV). NGS analysis revealed that distinct regions of MV genome were specifically recognized by distinct RLRs: RIG-I recognized defective interfering genomes, whereas MDA5 and LGP2 specifically bound MV nucleoprotein-coding region. During CHIKV infection, RIG-I associated specifically to the 3' untranslated region of viral genome. This study provides the first comparative view of the viral RNA ligands for RIG-I, MDA5 and LGP2 in the presence of infection.

Article and author information

Author details

  1. Raul Y Sanchez David

    Unité de Génomique Virale et Vaccination, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Chantal Combredet

    Unité de Génomique Virale et Vaccination, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Odile Sismeiro

    Transcriptome and Epigenome, BioMics Pole, Center for Innovation and Technological Research, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Marie-Agnès Dillies

    Transcriptome and Epigenome, BioMics Pole, Center for Innovation and Technological Research, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Bernd Jagla

    Transcriptome and Epigenome, BioMics Pole, Center for Innovation and Technological Research, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Jean-Yves Coppée

    Transcriptome and Epigenome, BioMics Pole, Center for Innovation and Technological Research, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Marie Mura

    Unité de Génomique Virale et Vaccination, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Mathilde Guerbois Galla

    University of Texas Medical Branch, Galveston, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Philippe Despres

    Technology platform CYROI, University of Reunion Island, Saint-Clotilde, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Frédéric Tangy

    Unité de Génomique Virale et Vaccination, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Anastassia V Komarova

    Unité de Génomique Virale et Vaccination, Institut Pasteur, Paris, France
    For correspondence
    stasy@pasteur.fr
    Competing interests
    The authors declare that no competing interests exist.

Copyright

© 2016, Sanchez David et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Raul Y Sanchez David
  2. Chantal Combredet
  3. Odile Sismeiro
  4. Marie-Agnès Dillies
  5. Bernd Jagla
  6. Jean-Yves Coppée
  7. Marie Mura
  8. Mathilde Guerbois Galla
  9. Philippe Despres
  10. Frédéric Tangy
  11. Anastassia V Komarova
(2016)
Comparative analysis of viral RNA signatures on different RIG-I-like receptors
eLife 5:e11275.
https://doi.org/10.7554/eLife.11275

Share this article

https://doi.org/10.7554/eLife.11275

Further reading

    1. Immunology and Inflammation
    Denise M Monack
    Insight

    Macrophages control intracellular pathogens like Salmonella by using two caspase enzymes at different times during infection.

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Ainhoa Arbués, Sarah Schmidiger ... Damien Portevin
    Research Article

    The members of the Mycobacterium tuberculosis complex (MTBC) causing human tuberculosis comprise 10 phylogenetic lineages that differ in their geographical distribution. The human consequences of this phylogenetic diversity remain poorly understood. Here, we assessed the phenotypic properties at the host-pathogen interface of 14 clinical strains representing five major MTBC lineages. Using a human in vitro granuloma model combined with bacterial load assessment, microscopy, flow cytometry, and multiplexed-bead arrays, we observed considerable intra-lineage diversity. Yet, modern lineages were overall associated with increased growth rate and more pronounced granulomatous responses. MTBC lineages exhibited distinct propensities to accumulate triglyceride lipid droplets—a phenotype associated with dormancy—that was particularly pronounced in lineage 2 and reduced in lineage 3 strains. The most favorable granuloma responses were associated with strong CD4 and CD8 T cell activation as well as inflammatory responses mediated by CXCL9, granzyme B, and TNF. Both of which showed consistent negative correlation with bacterial proliferation across genetically distant MTBC strains of different lineages. Taken together, our data indicate that different virulence strategies and protective immune traits associate with MTBC genetic diversity at lineage and strain level.